Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingxin Anshen Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed and studied primarily at Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine. The name translates to "clearing the heart and calming the spirit," reflecting its dual therapeutic focus on reducing internal "heat" (inflammation) and addressing neuropsychiatric symptoms such as anxiety and insomnia. In clinical research, it is often utilized as a functional module (or "dismantled formula") of the larger Xiaoyin Anshen Decoction. It is specifically investigated for its efficacy in treating psoriasis patients who suffer from comorbid sleep disorders, aiming to modulate the psychosomatic axis of the disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qingxin anshen decoction.